Home
Issues
Special Issues
For Authors
Topics
Web Exclusives
Conference Correspondent
About

Want to Receive News & Updates from AHDB?

Stay up to date on the latest information you need to devise benefit designs, make coverage decisions, and further value-based healthcare! Sign up for our newsletter or print publications today by entering your contact information below and clicking "Subscribe".

First Name *

Last Name *

Email Address *

Email Address (Verify) *

AHDB Print Edition

We will request your mailing address on the next page.

AHDB E-Newsletters & Communications

I have reviewed and consent to the terms of AHDB's Privacy Policy, and AHDB has my permission to retain my information in its database, and to forward pertinent communications to me.

Home
Issues
Special Issues
For Authors
Topics
Web Exclusives
Conference Correspondent
About

Ajay S. Behl, PhD

Authored Items

Medication Adherence, Treatment Patterns, and Dose Reduction in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Abiraterone Acetate or Enzalutamide

Gary M. Owens, MD, Ajay S. Behl, PhD, Lorie A. Ellis, PhD, Dominic Pilon, MA, Yongling Xiao, PhD

September 2017 Vol 10, No 6 in Clinical, Original Research

Assessment of Real-World Central Nervous System Events in Patients with Advanced Prostate Cancer Using Abiraterone Acetate, Bicalutamide, Enzalutamide, or Chemotherapy

Dominic Pilon, MA, Brian Caveney, MD, JD, MPH, Ajay S. Behl, PhD, Lorie A. Ellis, PhD, Marie-Noëlle Robitaille, MA, Patrick Lefebvre, MA, Nancy A. Dawson, MD

May 2017 Vol 10, No 3 in Clinical

Last modified: April 23, 2019

HOME
ABOUT
CONTACT US
TERMS OF USE
PRIVACY POLICY
ADVERTISING POLICY

Copyright © Engage Healthcare Communications, LLC. All rights reserved.